Your Top 100 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.
Ana Christina Garrido-Castro, Se Eun Kim, T. Li, Jennifer Desrosiers, Rita Nanda, Y. Abdou and 24 more
- Rank
- 69 of 3,853
- Percentile
- top 1.8%
- Where
- Annals of Oncology, 2024
- Citations
- 37
From the 2024 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.